Julien MONSENEGO

Partner

Julien MONSENEGO

Practice areas

Corporate taxation

Julien MONSENEGO is partner and co-head of the « Corporate taxation » department. He advises French and foreign companies on their domestic and international investments, strategic decisions, and day-to-day operations for more than twenty years.

He has significant experience in establishing policies and documentation for transfer pricing and cross-border tax structures, R&D and intangible assets (patent and software revenues, CIR) taxation as well as sub-plan of stock-options and other employee shareholding tools.

As longstanding legal counsel to a number of privately-owned groups, Julien MONSENEGO represents them on corporate tax issues (eg. restructurings, acquisitions, divestitures ...) but also on their interactions with individuals and wealth taxation regarding shareholders, including family-run groups, and managers.

He has particular expertise in the pharmaceutical industry, as well as a focus on generally R&D-intensive sectors such as software, agro-business and media.

Julien holds a DESS in Corporate Law and Finance (Lyon III) and he’s a graduate of EM Lyon.

Julien MONSENEGO regularly publishes articles in the international tax review « BNA ». He is also in charge of the French transfer pricing chapters of the « Transfer Pricing Forum », of the IBFD (International Bureau of Fiscal Documentation), and of the chapter on the taxation of industrial property at the Legislative Editions.

He is a member of the International Fiscal Association (IFA) and the French Tax Lawyers’ Institute (IACF).

News

DELSOL Avocats assisted Neoma Business School with the acquisition of MELTIS

DELSOL Avocats assisted Neoma Business School with the acquisition of the continuing education company MELTIS. This transaction is part of Neoma’s new 23-27 strategic plan, called « Engage For The Future ». It aims at accelerating the growth of the school, which hopes to triple its turnover in five years, and to increase its expertise in...

Read

French R&D tax incentives : overview and recent developments

French tax incentives remain a key point in the competitiveness of French research and development (“R&D”), thanks to three main items. Firstly, the research tax credit (“RTC”), which amounts to 30 % of the expenditures related to R&D up to 100 million euros and 5 % for the excess. The eligible expenses are quite broad and include in...

Read

PRESS RELEASE - DELSOL Avocats advised CDC (Banque des Territoires) and ADEME Investissement in the context of ZEWAY’s fundraising

DELSOL Avocats advised the CDC (Banque des Territoires) and ADEME Investissement on ZEWAY’s €26.75 million fundraising. ZEWAY is a leading player in « zero emission » urban mobility. This round of financing will enable ZEWAY to deploy its network of battery exchange stations for urban electric mobility on a large scale. Historical investors,...

Read